-   Training & Support

[Expand/Collapse all sections]Expand all

This document outlines details of PBS subsidised nintedanib and
pirfenidone for patients with idiopathic pulmonary fibrosis (IPF).

IPF and listing dates

IPF is a chronic condition affecting the lungs.

Listing dates are:

-   nintedanib - 1 May 2017
-    pirfenidone - 1 July 2017

See Written Authority Required Drugs for more information.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the option relevant to the condition
treated.

The Resources page contains links to application forms, contact details,
item and restriction codes, the PBS schedule and the Services Australia
website.

Related links

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

Processing and National Demand Allocation (PaNDA)

Process telephone Authority approval application

Processing Complex Authority Required Listings

Written Authority Required Drugs

                                   

-   Services Australia ABN 90 794 605 008 
